Evidence map›Paper›PMID 27035878›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Ablation of Glutaredoxin-1 Modulates House Dust Mite-Induced Allergic Airways Disease in Mice.

Sidra M Hoffman, Xi Qian, James D Nolin, David G Chapman, Shi Biao Chia, Karolyn G Lahue, Robert Schneider, Jennifer L Ather, Matthew J Randall, David H McMillan and 15 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Redox RegulationAntioxidants & redox signaling · 2020
    Review
  5. Dysregulation of the glutaredoxin/American journal of physiology. Cell physiology · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Animal models of asthma: utility and limitations.Journal of asthma and allergy · 2017
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 3 institutions in 2 countries.

Sidra M HoffmanDepartments of 1 Pathology and Laboratory Medicine and.
Xi QianDepartments of 1 Pathology and Laboratory Medicine and.
James D NolinDepartments of 1 Pathology and Laboratory Medicine and.
David G Chapman2 Medicine, University of Vermont, Burlington, Vermont.
Shi Biao ChiaDepartments of 1 Pathology and Laboratory Medicine and.
Karolyn G LahueDepartments of 1 Pathology and Laboratory Medicine and.
Robert SchneiderDepartments of 1 Pathology and Laboratory Medicine and.
Jennifer L Ather2 Medicine, University of Vermont, Burlington, Vermont.
Matthew J Randall2 Medicine, University of Vermont, Burlington, Vermont.
David H McMillanDepartments of 1 Pathology and Laboratory Medicine and.
Jane T JonesDepartments of 1 Pathology and Laboratory Medicine and.
Douglas J TaatjesDepartments of 1 Pathology and Laboratory Medicine and.
Minara Aliyeva2 Medicine, University of Vermont, Burlington, Vermont.
Nirav Daphtary2 Medicine, University of Vermont, Burlington, Vermont.
Sarah AbdallaDepartments of 1 Pathology and Laboratory Medicine and.
Lennart K A Lundblad2 Medicine, University of Vermont, Burlington, Vermont.
Ye-Shih Ho3 Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan; and.
Vikas AnathyDepartments of 1 Pathology and Laboratory Medicine and.
Charles G Irvin2 Medicine, University of Vermont, Burlington, Vermont.
Emiel F M Wouters4 Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
Niki L Reynaert4 Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
Anne E Dixon2 Medicine, University of Vermont, Burlington, Vermont.
Albert van der VlietDepartments of 1 Pathology and Laboratory Medicine and.
Matthew E Poynter2 Medicine, University of Vermont, Burlington, Vermont.
Yvonne M W Janssen-HeiningerDepartments of 1 Pathology and Laboratory Medicine and.
University of Vermont · USMaastricht University · NLWayne State University · US

Funding

Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
REGULATION OF NFKB IN LUNG EPITHELIUM BY ROS/RNSR01HL060014 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 1999 to 2016
$5.9M
Redox-based Fas Signaling in Allergic Airway DiseaseR01HL079331 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2005 to 2016
$4.2M
Translational Research in Lung Biology and DiseaseP30GM103532 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI IRVIN, CHARLES G · 2012 to 2016
$3.7M
Epithelial JNK-TGFb1 Signaling Axis in Airway RemodelingR01HL085464 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2008 to 2016
$3.0M
Cigarette Smoke-derived Electrophilic Aldehydes and Airway InflammationR01ES021476 · NIEHS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2012 to 2016
$1.9M
NHLBI NIH HHS R01 HL060014NHLBI NIH HHS R01 HL079331NHLBI NIH HHS R01 HL085464NHLBI NIH HHS T32 HL076122NIEHS NIH HHS R01 ES021476NIGMS NIH HHS P30 GM103532NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Protein S-glutathionylation (PSSG) is an oxidant-induced post-translational modification of protein cysteines that impacts structure and function. The oxidoreductase glutaredoxin-1 (Glrx1) under physiological conditions catalyzes deglutathionylation and restores the protein thiol group. The involvement of Glrx1/PSSG in allergic inflammation induced by asthma-relevant allergens remains unknown. In the present study, we examined the impact of genetic ablation of Glrx1 in the pathogenesis of house dust mite (HDM)-induced allergic airways disease in mice. Wild-type (WT) or Glrx1(-/-) mice were instilled intranasally with HDM on 5 consecutive days for 3 weeks. As expected, overall PSSG was increased in Glrx1(-/-) HDM mice as compared with WT animals. Total cells in bronchoalveolar lavage fluid were similarly increased in HDM-treated WT and Glrx1(-/-) mice. However, in response to HDM, mice lacking Glrx1 demonstrated significantly more neutrophils and macrophages but fewer eosinophils as compared with HDM-exposed WT mice. mRNA expression of the Th2-associated cytokines IL-13 and IL-6, as well as mucin-5AC (Muc5ac), was significantly attenuated in Glrx1(-/-) HDM-treated mice. Conversely, mRNA expression of IFN-γ and IL-17A was increased in Glrx1(-/-) HDM mice compared with WT littermates. Restimulation of single-cell suspensions isolated from lungs or spleens with HDM resulted in enhanced IL-17A and decreased IL-5 production in cells derived from inflamed Glrx1(-/-) mice compared with WT animals. Finally, HDM-induced tissue damping and elastance were significantly attenuated in Glrx1(-/-) mice compared with WT littermates. These results demonstrate that the Glrx1-PSSG axis plays a pivotal role in HDM-induced allergic airways disease in association with enhanced type 2 inflammation and restriction of IFN-γ and IL-17A.

Indexed as

AnimalsCytokinesGlutaredoxinsGlutathioneHyperplasiaHypersensitivityImmunoglobulin EImmunoglobulin GLungMice, Inbred BALB CMucusPneumoniaPyroglyphidaeRespiratory HypersensitivityRespiratory MechanicsRNA, MessengerCytokinesGlutaredoxinsGlutathioneImmunoglobulin EImmunoglobulin GRNA, MessengerasthmaIFN-γIL-17Aneutrophilsprotein S-glutathionylation

Identifiers

PMID27035878
PMCPMC5023028
OpenAlexW2314377370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.